Drug-labels.com

Mint-Simvastatin: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
5 mg, 10 mg, 20 mg, 40 mg, 80 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Mint-Simvastatin

What is MINT-SIMVASTATIN used for?

MINT-SIMVASTATIN is used in adults and children (10 to less than 18 years of age). It is used in combination with a change in diet, to:

  • lower the levels of cholesterol and fatty substances called triglycerides in the blood; and
  • reduce blockages in the arteries

In adults, MINT-SIMVASTATIN can reduce the chance of experiencing health risks associated with Coronary Heart Disease (CHD) such as heart attack, stroke, or death.

How does MINT-SIMVASTATIN work?

Simvastatin belongs to a class of medicines known as “statins”, more specifically called HMG- CoA reductase inhibitors. Statins block an enzyme called HMG-CoA reductase from being made in your liver, which is involved in the production of cholesterol in your body. MINT-SIMVASTATIN is used along with a change in diet, to help control the amount of cholesterol in your blood. Medicines like this one are prescribed along with, and not as a substitute for, a special diet and other measures.

What are the ingredients in MINT-SIMVASTATIN?

Medicinal ingredient: Simvastatin

Non-medicinal ingredients: Ascorbic acid, butylated hydroxyanisole, citric acid, hypromellose, hydroxypropyl cellulose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, pregelatinized starch, talc, and titanium dioxide. MINT-SIMVASTATIN 5 mg, 10 mg, 20 mg, 40 mg and 80 mg tablets contain yellow ferric oxide. MINT-SIMVASTATIN 10 mg, 20 mg, 40 mg and 80 mg tablets also contain red ferric oxide.

MINT-SIMVASTATIN comes in the following dosage forms:

Tablets: 5 mg (yellow), 10 mg (pink), 20 mg (brown), 40 mg (brick red) and 80 mg (brick red).

Do not use MINT-SIMVASTATIN if:

  • you are allergic to simvastatin or any non-medicinal ingredient in the MINT-SIMVASTATIN formulation.
  • you are pregnant, think you may be pregnant, or intend to become pregnant; if you become pregnant, stop taking MINT-SIMVASTATIN immediately and talk to your healthcare professional.
  • you are breastfeeding or intend to breastfeed.
  • you have active liver disease.
  • you are taking any of the following medicines:

    • certain antifungal medicines (itraconazole, ketoconazole, posaconazole, or voriconazole),
    • certain medicines used to treat HIV (nelfinavir, ritonavir, or saquinavir),
    • certain medicines used to treat hepatitis C virus (boceprevir or telaprevir),
    • certain antibiotics (erythromycin, clarithromycin, or telithromycin),
    • medicines containing cobicistat,
    • nefazodone, used to treat depression,
    • gemfibrozil, used for lowering cholesterol,
    • cyclosporine, used to prevent organ transplant rejection,
    • danazol, used to treat endometriosis or fibrocystic breast disease.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take MINT-SIMVASTATIN. Talk about any health conditions or problems you may have, including if you:

  • have diabetes or are at risk of having diabetes
  • have thyroid problems
  • regularly drink three or more alcoholic drinks daily
  • had any past problems with the muscles (pain, tenderness), after using medicines such as atorvastatin, fluvastatin, lovastatin, pravastatin or rosuvastatin
  • do excessive physical exercise
  • have kidney or liver problems
  • have undergone surgery or other tissue injury or if you have a planned surgery
  • are taking any other cholesterol lowering medication such as fibrates (fenofibrate), niacin or ezetimibe
  • are Asian
  • are 65 years of age or older
  • feel weak or frail
  • have or have had myasthenia gravis (a disease causing general muscle weakness including the eye muscles and in some cases, muscles used for breathing) as statins may lead to occurrence of myasthenia or aggravate the condition.

Other warnings you should know about:

Pregnancy: MINT-SIMVASTATIN should not be taken during pregnancy as it may harm your unborn baby. If you are a woman who could become pregnant, your healthcare professional will ask you to use a highly effective birth control method while taking MINT-SIMVASTATIN. If you discover you are pregnant while taking MINT-SIMVASTATIN, stop taking the medicine and contact your healthcare professional right away.

Muscle disorders (myopathy or rhabdomyolysis): MINT-SIMVASTATIN increases your risk of developing a severe muscle disorder. If you experience any unexplained muscle pain, tenderness or weakness, especially with a fever, tell your healthcare professional right away.

Testing and check-ups: Your healthcare professional may do blood tests before you start MINT-SIMVASTATIN and regularly during your treatment. These tests will check:

  • the amount of cholesterol and other fats in your blood
  • your liver function

Depending on your test results, your healthcare professional may adjust your dose, temporarily stop, or discontinue your treatment with MINT-SIMVASTATIN.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with MINT-SIMVASTATIN:

  • Fibrates, used to lower fat levels in the blood (such as fenofibrate or bezafibrate)
  • Amiodarone, used to treat an irregular heartbeat
  • Verapamil, diltiazem, or amlodipine, used to treat high blood pressure, angina, or other heart conditions
  • Lomitapide, used to treat a serious and rare genetic cholesterol condition
  • Niacin
  • Daptomycin, used to treat complicated skin and bacterial infections in the blood
  • Colchicine, used for gout
  • Cholestyramine, used to lower cholesterol
  • Anticoagulants, medications that prevent blood clots, such as warfarin or coumarin

    Serious Drug Interactions

Do not use MINT-SIMVASTATIN if you are taking any of the following:

  • certain antifungal medicines (itraconazole, ketoconazole, posaconazole, or voriconazole),
  • certain medicines used to treat HIV (nelfinavir, ritonavir, or saquinavir),
  • certain medicines used to treat hepatitis C virus (boceprevir or telaprevir),
  • certain antibiotics (erythromycin, clarithromycin, or telithromycin),
  • medicines containing cobicistat,
  • nefazodone, used to treat depression,
  • gemfibrozil, used for lowering cholesterol,
  • cyclosporine, used to prevent organ transplant rejection,
  • danazol, used to treat endometriosis or fibrocystic breast disease.

Taking MINT-SIMVASTATIN with any of these medications may cause a serious drug interaction. Ask your healthcare professional if you are unsure.

  • Digoxin, used to treat heart problems
  • Avoid drinking grapefruit juice while taking MINT-SIMVASTATIN

How to take MINT-SIMVASTATIN:

  • Take MINT-SIMVASTATIN exactly as your healthcare professional tells you to.
  • It is recommended to take MINT-SIMVASTATIN in the evening, with a meal.

  • Carefully follow any measures that your healthcare professional has recommended for diet, exercise or weight control.
  • When taking MINT-SIMVASTATIN, avoid consuming grapefruit juice.
  • Keep regular appointments with your healthcare professional so that your blood can be tested and your progress checked at proper intervals.

Usual dose:

The dose of MINT-SIMVASTATIN prescribed to you depends on your condition and/or your blood cholesterol level. Your healthcare professional may change your dose depending on your response to MINT-SIMVASTATIN.

  • For adults, the usual dosage is 5 mg to 40 mg once a day in the evening.
  • For children (10 to less than 18 years old), the usual dosage is 10 mg to 40 mg once a day in the evening. The maximum recommended dose is 40 mg a day.

Overdose:

Missed dose:

If you miss taking a tablet at its usual time, take it as soon as possible. However, if it is too close to the time of your next dose, skip the missed dose and take your next dose as scheduled. Do not take a double dose.

What are possible side effects from using MINT-SIMVASTATIN?

These are not all the possible side effects you may have when taking MINT-SIMVASTATIN. If you experience any side effects not listed here, tell your healthcare professional.

  • Persistent cough and/or shortness of breath
  • Erectile dysfunction
  • Acid reflux
  • Constipation
  • Diarrhea
  • Gas
  • Nausea

If you think you, or a person you are caring for, have taken too much MINT-SIMVASTATIN, contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even if there are no symptoms.

  • Abdominal pain or discomfort
  • Vomiting
  • Confusion
  • Dizziness
  • Headache
  • Memory loss
  • Poor memory
  • Hair loss
  • Itchy skin
  • Rash on the skin or inside the mouth (Lichen rash)
  • Trouble sleeping
  • Weakness

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
RARE
Allergic Reaction: difficulty swallowing or breathing, wheezing, drop in blood pressure, feeling sick to your stomach and throwing up, hives or rash, swelling of the face, lips, tongue or throat√

Liver Disorder: yellowing of the

skin or eyes, dark urine and pale stools, abdominal pain, nausea, vomiting, loss of appetite

√

Muscle Disorders:

Myopathy (muscle pain): aching muscles, tenderness or weakness that you cannot explain

Rhabdomyolysis (breakdown of damaged muscle): muscle tenderness, weakness, red-

brown (tea-coloured) urine These muscle disorders can be

accompanied with fever or feeling unwell.

√

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases

Myasthenia Gravis (muscle weakness):

General: difficulty in speaking, chewing, and swallowing or weakness of arms and legs and in some cases, muscles used when breathing

Ocular (eye): weak, drooping eyelid(s) causing vision changes

√
UNKNOWN

Blood Disorders:

Anaemia (decreased number of red blood cells): fatigue, loss of energy, irregular heartbeats, pale complexion, shortness of breath, weakness

Leukopenia (decreased white blood cells): infections, fatigue, fever, aches, pains and flu-like symptoms

Thrombocytopenia (low blood platelets): bruising or bleeding for longer than usual if you hurt

yourself, fatigue and weakness

√

Depression (sad mood that

won’t go away): difficulty sleeping or sleeping too much, changes in appetite or weight, feelings of worthlessness, guilt, regret, helplessness or hopelessness, withdrawal from social situations, family, gatherings and activities with friends, reduced libido (sex drive) and thoughts of death or suicide. If you have a history of depression, your depression

may become worse

√

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases

Hyperglycemia (high blood

sugar): increased thirst, frequent urination, dry skin, headache, blurred vision and fatigue

√
Interstitial lung disease (disease that inflames or scars lung tissue): shortness of breath when at rest that gets worse with exertion, dry cough√

Pancreatitis (inflammation of

the pancreas): upper abdominal pain, fever, rapid heartbeat, nausea, vomiting, tenderness

when touching the abdomen

√

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Storage:

Store your tablets at room temperature (15°C – 30°C), in the original package, away from heat and direct light, and out of damp places, such as the bathroom or kitchen.

Keep all medicines out of the reach and sight of children.

Do not use outdated medicine.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

If you want more information about MINT-SIMVASTATIN:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website: (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug- products/drug-product-database.html); or Mint Pharmaceuticals Inc. website www.mintpharmaceuticals.com or by calling Mint Pharmaceuticals Inc. at 1-877-398-9696.

Last Revised: JAN 24, 2024

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02372932

Revision date stated in the text: January 24, 2024

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Mint-Simvastatin

Rx or OTC
Prescription (Rx)?
DIN 02372932, 02372940, 02372959, 02372967, 02372975
Schedule(s) PRESCRIPTION
Active ingredient(s) Simvastatin
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C10 Lipid modifying agents
      1. C10A Lipid modifying agents, plain
        1. C10AA HMG CoA reductase inhibitors, plain lipid modifying drugs
          1. C10AA01 Simvastatin
Company MINT PHARMACEUTICALS INC
Current status Marketed
Current status date September 7, 2011
Strengths and forms
DIN Strength Dosage form(s) Current status
02372932 5 MG Tablet Marketed September 7, 2011
02372940 10 MG Tablet Marketed September 7, 2011
02372959 20 MG Tablet Marketed September 7, 2011
02372967 40 MG Tablet Marketed September 7, 2011
02372975 80 MG Tablet Marketed September 7, 2011

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.